BioCentury
ARTICLE | Clinical News

ABO-102: Phase I/II ongoing

October 10, 2016 7:00 AM UTC

A DSMB recommended continuation to the high-dose cohort of an open-label, U.S. Phase I/II trial evaluating single doses of 2 dose levels of IV ABO-102 based on a review of safety data from 3 patients ...